TESTBANK Understanding Pharmacology: Essentials for Medication Safety 3rd Edition

Test Bank for Understanding Pharmacology Essentials for Medication Safety,
3rd Edition by M. Linda Workman & LaCharity

,Chapter5v01:5vDrug5vRegulation,5vActions,5vand5vResponses
Workman5v&5vLaCharity:5vUnderstanding5vPharmacology:5vEssentials5vfor5vMedication5vSafety,5v3rd5vEdit
ion

MULTIPLE5vCHOICE5vBASIC5 v CON

CEPTS

1. Which5vhealth5vcare5vprofessional5vhas5vthe5vmajor5vresponsibility5vfor5vdispensing5vprescri
bed5 v drugs5vunder5vthe5vdirection5vof5va5vpharmacist?
a. Physician
b Nurse5vpractitioner
.
c. Licensed5vnurse
d Pharmacy5vtechnicia
. n


ANS:5v5 v D
The5vphysician5vand5vnurse5vpractitioner5vhave5vthe5vmajor5vresponsibility5vfor5vprescribing5vdrugs,5vnot5
v dispensing5vthem.5vThe5vlicensed5vnurse5vhas5vthe5vprimary5vresponsibility5vfor5vadministering5vdrugs,

5 v although5vunder5vsome5vcircumstances5va5vlicensed5vnurse5vmay5vdispense5vprescribed5vdrugs5vbut5vthi

s5vis5vnot5 v his5vor5vher5vmajor5vresponsibility5vin5vdrug5vtherapy.5vThe5vpharmacy5vtechnician5vhas5vthe5v
major5 v responsibility5vof5vdispensing5vprescribed5vdrugs5vunder5vthe5vdirection5vof5va5vlicensed5vpharma
cist.

DIF: Cognitive5vLevel:5vRemembering REF: p.5v3

2. Which5vterm5vdescribes5vthe5veffect5vof5va5vdrug5vthat5vimproves5vbody5vfunction?
a. Side5veffect
b Intended5vactio
. n
c. Adverse5vreaction
d Idiosyncratic5vresponse
.


ANS:5v5 v B
The5vpurpose5vof5vdrug5vtherapy5vis5vto5vtake5va5vdrug5vto5vprevent,5vreduce,5vor5vcorrect5va5vhealth5vproblem.5v
This
response5vis5vany5vdrug’s5vintended5vaction5valso5vknown5vas5va5vtherapeutic5vresponse.

DIF: Cognitive5vLevel:5vRemembering REF: p.5v3

3. Which5vtype5vof5vdrug5vname5vis5v“owned”5vby5vthe5vcompany5vthat5vmanufactures5vit?
a. Generic5vname
b Chemical5vname

,.
c. Category5vname
d Trade5vnam
. e


ANS:5v5 v D
The5vchemical5vname5vis5va5vdrug’s5vexact5vchemical5vcomposition.5vThe5vgeneric5vname5vis5vthe5vname5vass
igned5vto5 v the5vdrug5vby5vthe5vU.S.5vAdopted5vNames5vCouncil5vand5vis5vnot5vowned5vby5vanyone.5vThe5vcate
gory5vname5vrefers5 v to5vthe5vtype5vof5vdrug5v(what5vit5vdoes5vor5vwhat5vit5vis5vused5vfor)5vand5vis5vnot5van5vact
ual5vdrug5vname.5vThe5vtrade5 v name5v(brand5vname)5vis5vthe5vname5vprovided5vand5vowned5vby5va5vspecific
5vdrug’s5v manufacturer.



DIF: Cognitive5vLevel:5vRemembering REF: p.5v4

4. Which5vdrug5vor5vdrug5vclass5vis5va5v“high5valert”5vd
a. Penicillin
rug?
b Insulin
.
c. NSAIDs
d Calcium
.


ANS:5v5 v B
A5vhigh5valert5vdrug5vis5vone5vin5vwhich5vharm5vis5vlikely5vto5vresult5vif5vgiven5vat5vthe5vwrong5vdose,5vto5vthe5v
wrong5 v patient,5vor5vnot5vgiven5vto5vthe5vcorrect5vpatient.5vDrugs5vclassified5vas5vhigh5valert5vdrugs5vinclude
5vpotassium,5 v narcotics5v(opioids),5vinsulin,5vcancer5vchemotherapy5vdrugs,5vand5vheparin5v(or5vany5vdru

g5vthat5vstrongly5 v affects5vblood5vclotting).5vPenicillin,5vNSAIDs,5vand5vcalcium5vare5vnot5vconsidered5vhig
h5valert5vdrugs.

DIF: Cognitive5vLevel:5vRemembering REF: p.5v4

5. What5vis5vthe5vterm5vfor5va5vdrug5vthat5vhas5vthe5vsame5vaction5vas5va5vnaturally5voccurrin
g5vbody5 v hormone5vor5venzyme?
a. Agonist
b Blocking5vagent
.
c. Chemical
d Duplicator
.


ANS:5v5 v A
A5vdrug5vagonist5vis5van5vextrinsic5vdrug5vthat5vactivates5vthe5vreceptor5vsites5vof5va5vcell5vand5vmimics5vthe5vactio
ns5vof5 v naturally5voccurring5vbody5vsubstances5v(intrinsic5vdrugs).5vA5vblocking5vagent5vis5va5vdrug

, antagonist.5vA5vchemical5vwould5vnot5vnecessarily5vbe5va5vdrug5vat5vall.5vA5vduplicator5vis5vnot5va5vpharmacologi

c5vterm.5 v DIF: Cognitive5vLevel:5vRemembering REF: pp.5v6-

7

6. Which5vterm5vdescribes5vhow5vthe5vbody5vaffects5vdrug5vactivity?
a. Drug5vpotency
b Pharmacodynamics
.
c. Therapeutic5veffect
d Pharmacokinetics
.


ANS:5v5 v D
The5vterm5vpharmacokinetics5vrefers5vto5vdrug5vmetabolism5vand5vhow5vthe5vbody5vchanges5va5vdrug.5 v Ph
armacodynamics5vrefers5vto5vhow5va5vdrug5vworks5vto5vchange5vbody5vfunction.5vDrug5vpotency5vrefers5vto5vh
ow5 v strongly5vor5vto5vwhat5vdegree5va5vdrug5vexerts5vits5veffects.5vThe5vtherapeutic5veffect5vis5vcloser5vto5 v p
harmacodynamics,5vmeaning5vhow5va5vdrug5vworks5vto5vchange5vbody5vfunction.

DIF: Cognitive5vLevel:5vRemembering REF: p.5v10

7. In5vthe5vUnited5vStates,5vwhich5vgroup5vis5vresponsible5vfor5venforcing5vestablished5vstandard
s5vfor5 v drug5vmanufacturing?
a. U.S.5vPharmacopeia
b National5vInstitutes5vof5vHealth
.
c. Food5vand5vDrug5vAdministratio
d Association
n 5vof5vPharmaceutical5vManufacturers

.


ANS:5v5 v C
The5vstandards5vfor5vdrug5vmanufacture5vare5vestablished5vby5vthe5vU.S.5vPharmacopeia.5vThese5 v standa
rds5vare5 v enforced5 v by5 v the5 v Food5 v and5 v Drug5 v Administration.5 v Neither5 v the5 v National5 v Institutes5
v of5 v Health5 v nor5 v the5 v Association5vof5vPharmaceutical5vManufacturers5vhas5vany5vauthority5vto5venforce

5vdrug5vstandards.



DIF:5v5v5v5 v Cognitive5vLevel:5vRemembering5v5v5v5v5v5v5v5v5 v REF:5v5v5 v p.5v5

8. Which5vfactor5vis5va5vmajor5vdisadvantage5vof5vthe5vtransdermal5vdrug5vdelivery5vroute?
a. Only5va5vprescriber5vcan5vadminister5vdrugs5vby5vthe5vtransdermal5vroute
b .
Transdermal 5vdrugs5vmust5vbe5vsterile5vrather5vthan5vclean.

.
c. First5vpass5vdrug5vloss5vby5vthis5vroute5vis5vthe5vmost5vextensive.
d Drug5vabsorption5vis5vdependent5von5vadequate5vcirculati
on.